Advances in understanding and management of IgG4-related ophthalmic disease
Asia-Pacific Journal of Ophthalmology · 2024-09 · 13 (5) · 100101
DOI: 10.1016/j.apjo.2024.100101 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2024-09. Verfasst von Kenneth Ka Hei Lai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China; Department of Ophthalmol…. Hauptthemen laut MEDLINE: Immunoglobulin G4-Related Disease, Immunoglobulin G. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Immunoglobulin G4-related ophthalmic disease (IgG4-ROD) is an emerging, immune-mediated fibroinflammatory orbital disease, characterized by tumefactive lesions with noticeable IgG4+ plasma cell infiltration and distinctive pathohistological features. This disease is often associated with elevated serum IgG4 concentrations. IgG4-ROD may affect any ophthalmic tissues, particularly the lacrimal gland, extraocular muscles, and trigeminal nerves. Although the exact pathogenic role of IgG4 antibodies remains unclear, B-cell depleting agents have been reported to be an effective treatment. The diverse clinical manifestations of IgG4-ROD complicate diagnosis, and without prompt treatment, visual-threatening complications such as optic neuropathy may arise. Recent advances in understanding and managing IgG4-ROD have revolutionized the diagnosis and treatment of this emerging disease. This review article aims to provide a comprehensive overview of the latest advancements in the field of IgG4-ROD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China; Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China.
- The University of Adelaide, Adelaide, South Australia, Australia.
- Department of Pathology, Queen Elizabeth Hospital, Hong Kong, China.
- Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shan…
- The Goldschleger Eye Institute, Sheba Medical Center, Tel HaShomer, Israel.
- South Australian Institute of Ophthalmology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Zitieren
APA
Lai, K. K. H., Ang, T. W. X., Cheuk, W., Kwok, A., Lin, M., Lustig, Y., Selva, D., Ben Simon, G., Xing, Y., Xu, Z. H., Yang, H. S., Chong, K. K. L., & Yuen, H. K. L. (2024). Advances in understanding and management of IgG4-related ophthalmic disease. Asia-Pacific Journal of Ophthalmology, 13(5), 100101. https://doi.org/10.1016/j.apjo.2024.100101
Vancouver
Lai KKH, Ang TWX, Cheuk W, Kwok A, Lin M, Lustig Y, et al. Advances in understanding and management of IgG4-related ophthalmic disease. Asia-Pacific Journal of Ophthalmology. 2024;13(5):100101. doi:10.1016/j.apjo.2024.100101
BibTeX
@article{Lai2024,
author = {Lai, Kenneth Ka Hei and Ang, Terence Wee Xiang and Cheuk, Wah and Kwok, Angie and Lin, Ming and Lustig, Yael and Selva, Dinesh and Ben Simon, Guy and Xing, Yue and Xu, Zhi Hui and Yang, Hua Sheng and Chong, Kelvin Kam Lung and Yuen, Hunter Kwok Lai},
title = {Advances in understanding and management of IgG4-related ophthalmic disease},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2024},
volume = {13},
number = {5},
pages = {100101},
doi = {10.1016/j.apjo.2024.100101}
}
EUVIMED